Pharmaceutical composition containing an isolated protease proen

Details Pharmaceutical composition containing an isolated protease proen Pharmaceutical composition containing an isolated protease proen

1996-05-17

1999-01-12

Naff, David M.

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

424 942, 424 9421, 424 943, 424 946, 424 9463, 435184, 435201, 435202, 435204, 435213, 435218, 435220, 435226, A61K 3848, A61K 3854, C12N 926, C12N 976

Patent

active

058583572

ABSTRACT:
The invention is directed to a pharmaceutical preparation with a modulatory effect on malignant tumors, which contains a combination of protease proenzymes and amylases in a ratio between 1:100 and 100:1 in enzymatic activity units, and a protease inhibitor. The invention is also directed to use of such a preparation to modulate the effects of malignant tumors in humans and animals.

REFERENCES:
patent: 3956483 (1976-05-01), Lewis
Rawn, Biochemistry, Harper & Row, Publishers, Inc., NY, NY, pp. 214-218 and 479, 1983.
Sigma Catalog, pp. 125 and 586, 1991.

Affiliated with

Also associated with

Rating

Pharmaceutical composition containing an isolated protease proen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition containing an isolated protease proen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing an isolated protease proen will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1511854